FBC The Willis Report October 2, 2014
Ebola, especially when bureaucratic red tape is holding up companies from developing vaccines for just these kind of outbreaks . With more on this, david dod, chairman of the board of directors at geovax. Dr. Kevin campbell, assistant professor of medicine at university of the North Carolina. Welcome to you both. David, i want to start with you because youre the perfect guest for this segment because your company, geovakx is in process developing a vaccine for ebola. What are the hurdles putting together a drug that could combat this deadly disease . Yes, thank you. First of all, thank you for...